STOCK TITAN

Rentokil Initial Plc SEC Filings

RTO NYSE

Welcome to our dedicated page for Rentokil Initial Plc SEC filings (Ticker: RTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking pest-control acquisitions, cross-border revenue splits, or executive stock sales in Rentokil Initial’s SEC docket can feel like chasing insects in the dark. The London-based leader’s route-based pest and hygiene model spans 80+ countries, so each Form 6-K, 20-F, or swift 8-K arrives packed with segment data, currency translations, and risk factors. If you have ever searched “Rentokil Initial SEC filings explained simply” or wondered about “Rentokil Initial insider trading Form 4 transactions” before the market reacts, this page lights the way.

Stock Titan’s AI reads every submission the instant it lands on EDGAR and translates dense text into plain-English briefs. Whether you type “Rentokil Initial quarterly earnings report 10-Q filing” (mapped to the nearest 6-K), “Rentokil Initial annual report 10-K simplified” (our link to the Form 20-F), or “Rentokil Initial proxy statement executive compensation”, the platform pinpoints the numbers that matter—like hygiene-segment margins or integration costs from the Terminix deal. Real-time alerts surface “Rentokil Initial Form 4 insider transactions real-time” so you never miss developing trends.

  • Form 20-F / 10-K equivalent: global revenue splits, pest-control margins, major risks
  • 6-K / 10-Q style updates: quarterly hygiene performance and cash generation
  • Form 4: Rentokil Initial executive stock transactions Form 4 with instant AI context
  • 8-K: “Rentokil Initial 8-K material events explained” for acquisitions and leadership changes

Use the dashboard for “Rentokil Initial earnings report filing analysis,” compare route-based growth, or download data tables. By “understanding Rentokil Initial SEC documents with AI,” you focus on decisions, not document hunting.

Rhea-AI Summary

Janus Henderson Group plc reports beneficial ownership of common stock in Rentokil Initial plc totaling 142,879,790 shares, representing approximately 5.7% of the class. The filing identifies the reporting person as an investment adviser (Type IA, HC) and discloses that certain indirect subsidiaries (including JHIUS) may be deemed beneficial owners of a portion of the position, with JHIUS shown as beneficially owning 127,751,451 shares (about 5.1% of the class).

The filing states these securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer. A power of attorney authorizes named company employees to execute filings on Janus Henderson's behalf.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

H1 2025 highlights: Revenue from continuing operations grew 3.1 % YoY to $3.36 bn (1.6 % organic). Adjusted operating profit slipped 4.5 % to $511 m, cutting margin 120 bps to 15.2 %. Adjusted PBT was $418 m (-7.8 %) and adjusted EPS 12.46 c (-11 %). Statutory PBT fell 26 % to $216 m after a $79 m increase in the termite-damage provision.

Cash & capital: Free cash flow rose 31 % to $282 m with 93 % conversion (vs 80 % guidance). Net debt climbed to $4.22 bn, or 2.8× adjusted EBITDA, largely due to bond financing and FX; liquidity headroom is $2.0 bn. Interim dividend maintained at 4.15 c.

Operating trends: North America revenue +2.0 % (organic +1.1 %) but adjusted profit -7.3 % and margin 16.9 %. International revenue +5.1 %, adjusted profit +4.6 %, margin steady at 19.3 %. Group organic growth improved in Q2, with North America organic growth 1.4 % versus 0.7 % in Q1. Integration of Terminix continues; ~$100 m cost-reduction target and >20 % NA margin post-2026 reiterated. FY-25 outlook and technical guidance unchanged.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

On 24 Jul 2025 sovereign wealth fund GIC Private Limited crossed a disclosure threshold in Rentokil Initial plc, triggering this Form 6-K/TR-1 major-holdings notice. GIC now controls 6.494659 % of Rentokil’s voting rights, equal to 164.06 million votes. The stake consists of 5.940639 % (150.06 m votes) held via ordinary shares and 0.554020 % (13.99 m votes) linked to security-lending arrangements.

The change is primarily a reclassification of part of the holding as “security lending” rather than a meaningful purchase or sale; the previously reported total was 6.500133 %. No financial results, guidance or operational updates are included. The filing, dated 28 Jul 2025, fulfils UK Disclosure & Transparency Rule 5 obligations and has limited direct impact on Rentokil’s fundamentals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Rentokil Initial Plc (RTO)?

The current stock price of Rentokil Initial Plc (RTO) is $24.4 as of August 22, 2025.

What is the market cap of Rentokil Initial Plc (RTO)?

The market cap of Rentokil Initial Plc (RTO) is approximately 12.3B.
Rentokil Initial Plc

NYSE:RTO

RTO Rankings

RTO Stock Data

12.32B
505.20M
0%
13.12%
0.44%
Specialty Business Services
Industrials
Link
United Kingdom
Crawley